Andros Pharmaceuticals Co.,Ltd (TPEX:6917)
Taiwan · Delayed Price · Currency is TWD 30.00
-0.90 (-2.91%)
May 29, 2026, 1:42 PM CST
TPEX:6917 Market Cap
TPEX:6917 has a market cap or net worth of 1.37 billion as of May 29, 2026. Its market cap has increased by 70.89% in one year.
Market Cap
1.37B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
30.00
Market Cap Chart
Since January 12, 2023, TPEX:6917's market cap has increased from 1.11B to 1.37B, an increase of 22.74%. That is a compound annual growth rate of 6.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 1.37B | 23.87% |
| Dec 31, 2025 | 1.10B | 43.17% |
| Dec 31, 2024 | 770.08M | -30.92% |
| Dec 29, 2023 | 1.11B | 0.19% |
| Jan 12, 2023 | 1.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TaiRx | 1.68B |
| Great Novel Therapeutics Biotech & Medicals | 1.64B |
| Advagene Biopharma | 1.52B |
| Bio Preventive Medicine | 1.46B |
| GenMont Biotech Incorporation | 1.41B |
| NeoCore Technology | 1.32B |
| Abnova (Taiwan) | 1.24B |
| Enimmune | 1.23B |